Results 1 to 10 of about 12,522,600 (400)

Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution

open access: yesMedical Science Monitor, 2023
The 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report includes relevant topics from the clinician’s perspective and evidence published on chronic obstructive pulmonary disease (COPD) since GOLD 2017. The World Health Organization (
D. Parums
semanticscholar   +1 more source

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary

open access: yesEuropean Respiratory Journal, 2023
Executive summary of the Global Strategy for Prevention, Diagnosis and Management of COPD 2023: the latest evidence-based strategy document from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) https://bit.ly ...
A. Agustí   +20 more
semanticscholar   +1 more source

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.

open access: yesNew England Journal of Medicine, 2021
BACKGROUND No therapies are currently approved for the treatment of pulmonary hypertension in patients with interstitial lung disease. The safety and efficacy of inhaled treprostinil for patients with this condition are unclear.
A. Waxman   +15 more
semanticscholar   +1 more source

Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment

open access: yesAnnals of the American Thoracic Society, 2021
Rationale: The natural history of recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unknown. Because fibrosis with persistent physiological deficit is a previously described feature of patients recovering from similar ...
K. Myall   +10 more
semanticscholar   +1 more source

Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management

open access: yesEuropean Respiratory Review, 2021
Rheumatoid arthritis (RA) is a systemic inflammatory disorder, with the most common extra-articular manifestation of RA being lung involvement. While essentially any of the lung compartments can be affected and manifest as interstitial lung disease (ILD),
S. Kadura, G. Raghu
semanticscholar   +1 more source

Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease

open access: yesThorax, 2021
Cigarette smoking is the leading cause of preventable death worldwide. It causes chronic lung disease and predisposes individuals to acute lung injury and pulmonary infection.
S. Lugg   +4 more
semanticscholar   +1 more source

An integrated cell atlas of the lung in health and disease

open access: yesNature Network Boston, 2023
Single-cell technologies have transformed our understanding of human tissues. Yet, studies typically capture only a limited number of donors and disagree on cell type definitions.
L. Sikkema   +97 more
semanticscholar   +1 more source

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease

open access: yesAmerican Journal of Respiratory and Critical Care Medicine, 2020
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has raised many questions about the management of patients with chronic obstructive pulmonary disease (COPD) and whether modifications of their therapy are required.
D. Halpin   +7 more
semanticscholar   +1 more source

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019

open access: yesEuropean Respiratory Journal, 2019
Precision medicine is a patient-specific approach that integrates all relevant clinical, genetic and biological information in order to optimise the therapeutic benefit relative to the possibility of side-effects for each individual.
Dave Singh   +20 more
semanticscholar   +1 more source

The Rise of Non-Tuberculosis Mycobacterial Lung Disease

open access: yesFrontiers in Immunology, 2020
The incidence and number of deaths from non-tuberculous mycobacterial (NTM) disease have been steadily increasing globally. These lesser known “cousins” of Mycobacterium tuberculosis (TB) were once thought to be harmless environmental saprophytics and ...
C. Ratnatunga   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy